Trial
NCT02385084
A Study of LY2409021 Formulations in Healthy Participants
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Eli Lilly and Company
Collaborators
—
Condition
Healthy
Intervention
LY2409021
Why stopped
Part B of the study no longer required due to new information on the study drug.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-10-29